Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases.
about
A Liver-Centric Multiscale Modeling Framework for XenobioticsIn vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice.Robust regulation of hepatic pericentral amination by glutamate dehydrogenase kinetics.Highlight report: New methods for quantification of bile canalicular dynamics.Systems Toxicology.Large-scale computational models of liver metabolism: How far from the clinics?Zonation of hepatic fat accumulation: insights from mathematical modelling of nutrient gradients and fatty acid uptake.Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage.Adverse outcome pathways: opportunities, limitations and open questionsPossibilities and limitations of intravital imaging.Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk.Creation of Three-Dimensional Liver Tissue Models from Experimental Images for Systems Medicine.Computational Modeling in Liver Surgery.Highlight report: Metabolomics in hepatotoxicity testing.Highlight report: The pseudolobule in liver fibrosis.Highlight report: Monitoring cytochrome P450 activities in living hepatocytes.Highlight report: physiologically-based modeling of diseased liver tissue.Highlight report: co-cultures of hepatocytes and macrophages for hepatotoxicity testing.Highlight report: adaptations of the biliary tree to cholestasis.Assessment of stem cell differentiation based on genome-wide expression profilesModeling of xenobiotic transport and metabolism in virtual hepatic lobule models
P2860
Q27323311-E287A8E6-B168-4272-99D6-A1270F8DCB38Q30839160-D9D6DAF9-50BC-4805-9957-926EF13EB643Q36164717-773D4F15-BDE0-4E8F-AD82-42FADED43F31Q38269317-970C3E9D-4DC8-4FDE-9456-5E57368827BCQ38269384-939908F2-E1DD-4421-8ABD-D65007E3DA92Q39315101-2EFA3583-DBC6-483B-A5EC-8614FEA80631Q40081986-C5E0BF70-A4E0-4BB5-846B-590E17BCE7DCQ41109384-71690B62-E296-4B40-978E-F1EFB2C0A6C3Q42307037-BA4F6E4A-28E7-472A-A0B9-BE9205356F75Q42317721-4EB5F640-7E81-4515-90BA-6CB9639F1358Q42933280-7A2A9B2D-5ED7-40C3-A4CA-EBC33C4F62B8Q46166158-F695DC1C-34AC-4F05-B86F-410272B25C28Q47145823-81297522-B9F3-46A6-99AF-16657148ABDFQ49170889-B39A674E-5CFF-412D-932E-3E6B61CF10F8Q49185998-12FD49D0-4C1E-4E83-94BC-DFA41DF372C6Q49218533-3D2E8D08-F351-4158-A61B-216B467B96B3Q49607107-B967F59D-E014-4E2E-BCC5-1282C5F325EFQ53726413-91A0C942-11A7-4699-830E-EFE92F2DE962Q53727829-CEA64D91-89C9-4C78-8389-8A7F2AF7610EQ56964670-0F70F26B-C5A7-45A6-899E-B3E76A38613DQ58744433-FC9DE228-E0F3-4648-8E58-00AC331F9408
P2860
Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Model-guided identification of ...... erammonemia in liver diseases.
@en
type
label
Model-guided identification of ...... erammonemia in liver diseases.
@en
prefLabel
Model-guided identification of ...... erammonemia in liver diseases.
@en
P2093
P50
P1476
Model-guided identification of ...... erammonemia in liver diseases.
@en
P2093
Dieter Häussinger
Dirk Drasdo
Dominik Driesch
Géraldine Cellière
Meinolf Blaszkewicz
Patricio Godoy
Raymond Reif
Rolf Gebhardt
Sebastian G Henkel
Sebastian Zellmer
P304
P356
10.1016/J.JHEP.2015.11.018
P50
P577
2015-11-27T00:00:00Z